Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621

Watchlist Manager
Beijing Sun-Novo Pharmaceutical Research Co Ltd Logo
Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
Watchlist
Price: 72.83 CNY 0.32% Market Closed
Market Cap: ¥8.2B

Operating Margin

15.8%
Current
Declining
by 5.4%
vs 3-y average of 21.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.8%
=
Operating Income
¥174.5m
/
Revenue
¥1.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.8%
=
Operating Income
¥174.5m
/
Revenue
¥1.1B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
8.2B CNY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Higher than 81% of companies in China
Percentile
81st
Based on 8 544 companies
81st percentile
15.8%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Beijing Sun-Novo Pharmaceutical Research Co Ltd
Glance View

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2021-06-21. The firm's main businesses include comprehensive research and development services in generic drug development, consistency evaluation and innovative drug development. Its services mainly include pharmaceutical research, clinical trials and biological analysis. Pharmaceutical research services include raw materials and preparation process research, quality standards and stability research, etc. Clinical trial services include phase I-IV clinical trial research, Bioequivalency (BE) test research. Biological analysis services include the use of mass spectrometry analysis platform, immunoassay platform, cell analysis platform, molecular biology analysis platform for method development, method validation, biological sample detection research, etc. The firm mainly conducts its businesses in the domestic market.

Intrinsic Value
77.52 CNY
Undervaluation 6%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.8%
=
Operating Income
¥174.5m
/
Revenue
¥1.1B
What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's current Operating Margin?

The current Operating Margin for Beijing Sun-Novo Pharmaceutical Research Co Ltd is 15.8%, which is below its 3-year median of 21.2%.

How has Operating Margin changed over time?

Over the last 3 years, Beijing Sun-Novo Pharmaceutical Research Co Ltd’s Operating Margin has decreased from 25.2% to 15.8%. During this period, it reached a low of 13.1% on Mar 31, 2025 and a high of 25.2% on Jun 30, 2022.

Back to Top